Article

Cross-linking stability remarkable

Corneal crosslinking showed remarkable stability in a recent rabbit study, Dr Gregor Wollensak told delegates during the session on New Surgical Approaches to Keratoconus.

Corneal crosslinking showed remarkable stability in a recent rabbit study, Dr Gregor Wollensak told delegates during the session on New Surgical Approaches to Keratoconus.

"There are good prospects for the long-term stability of the technique, which is of course underlined by the very promising results from the Dresden five-year study, " he said.

Dr Wollensak outlined the biomechanical characteristics of the cornea after collagen crosslinking. "What is crosslinking in every day experience? " he asked. "Age-related crosslinking is where the meat of young animals is soft and tender whereas the meat of older animals is tough. "

Cataract, he said, was an example of crosslinking within the crystalline lens and that chemical crosslinking is demonstrated with formalin-induced hardening in tissue fixation.

He said this was a useful phenomenon in keratoconus because tensile strength of the cornea is reduced about 36% in that condition.

He outlined the standard procedure and told delegates: "So far, so good, but there are two outstanding questions that remain unanswered: What about C3-R? What about long-term stability of the biomechanical effect? "

He explained that C3-R (corneal collagen crosslinking with riboflavin) was introduced in 2004 by Dr. Boxer Wachler to reduce postoperative pain. It uses preoperative anaesthetic eye drops containing benzalkoniumchloride (BAK). This loosens up the tight junctions of the corneal epithelial cells thus allowing transepithelial crosslinking treatment without removal of the epithelium.

Dr Wollensak designed a rabbit experiment to test the efficacy of C3-R against standard corneal crosslinking. Group 1 (corneal crosslinking, n=5) had epithelial debridement, conjuncain and standard riboflavin solution starting 10 min before irradiation.

Group 2 (C3-R; n=5) had no debridement and proparacaine anaesthetic containing BAK starting 30 min before irradiation. Group 3 (C3-R without BAK; n=4) had no debridement, received conjuncaine without BAK 30 min before irradiation.

Results showed that corneal crosslinking had a marked effect on collagen hardening, while C3-R with BAK demonstrated one-fifth of the effect, while C3-R had actually reduced hardness in the cornea.

Dr Wollensak said that human corneas demonstrated a greater crosslinking effect than rabbits, by a factor of 2.5 "A higher degree of natural baseline crosslinking in rabbit cornea means there is more potential for an increase in crosslinking in the human cornea, " he said.

He said in human corneas the result of the rabbit experiment would probably correspond to 65% increase in corneal hardening by C3-R (320% by corneal crosslinking). "On histology, there was only toxicity down to 200 µm. So, C3-R can be recommended for thin corneas due to lower toxicity, but not for routine crosslinking, " Dr Wollensak said.

He also studied the stability of the effect in rabbits, testing the collagen crosslinking effect at one day, three months and eight months.

He said that the long term stability of the biomechanical effect of corneal crosslinking over eight months was remarkable. "Corneal collagen turnover rate is probably very slow like in the tendon or skin, so there are excellent prospects for the stability of corneal crosslinking. "

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.